Piperazine → N-[4-(1-Piperazinyl)butyl]-3,3-dimethylglutarimide

HRID 2199046

반응식

HRID 2199046 반응식
Br[CH2:2][CH2:3][CH2:4][CH2:5][N:6]1[C:11](=[O:12])[CH2:10][C:9]([CH3:14])([CH3:13])[CH2:8][C:7]1=[O:15].CC1(C)CC(=O)NC(=O)C1.[NH:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1.C([O-])([O-])=O.[K+].[K+]>C(#N)C>[N:26]1([CH2:2][CH2:3][CH2:4][CH2:5][N:6]2[C:11](=[O:12])[CH2:10][C:9]([CH3:14])([CH3:13])[CH2:8][C:7]2=[O:15])[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1

참가 물질

6

실험 절차

A mixture of N-(4-bromobutyl)-3,3-dimethylglutarimide (20.0 g; 0.07 mole [prepared from 3,3-dimethylglutarimide using the method of Example 2]); piperazine (31.0 g; 0.36 mole); K2CO3 (29.8 g; 0.22 mole); and KI (0.1 g) was refluxed in 250 mL acetonitrile for 18 hr. The mixture was filtered, concentrated and the unreacted piperazine removed by vacuum sublimation. The residual material was distilled to yield 17.2 g (85%) product, b.p. 170°-178° C. at 0.01 mm.

후처리

  1. filtrationThe mixture was filtered
  2. concentrationconcentrated
  3. customthe unreacted piperazine removed by vacuum sublimation
  4. distillationThe residual material was distilled

출처 및 근거

ORD 기록
ord-613b4dba2a814f92b4367ed0edb4cfd4
출처 데이터셋
uspto-grants-1982_11
특허 번호
US04361565

연결된 노트

불러오는 중…